Prof. Dr. med. Carola Berking

Lehrstuhl für Haut- und Geschlechtskrankheiten

Complete lymph node dissection versus selective lymph node extirpation in melanoma patients with nodal macrometastasis and adjuvant systemic therapy (2026) Mayer KE, Hassel JC, Sambale J, Erdmann M, Sindrilaru MA, Oberschmied J, Thiem A, et al. Journal article Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy (2026) Dugas-Breit S, Forschner A, Erdmann M, Gutzmer R, Kähler KC, Holst I, Brekner A, et al. Journal article Successful treatment of severe retroauricular pyoderma gangrenosum with upadacitinib in a patient with Crohn’s disease and a history of cerebral venous sinus thrombosis (2026) Fousekis F, Ronicke M, Sollfrank L, Rech J, Berking C, Neurath MF, Sticherling M, Atreya R Journal article Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis (2026) Geidel G, Bänsch S, Adam L, Fekade N, Rünger A, Zell T, Smit DJ, et al. Journal article Holistic Value Assessment of Tirbanibulin for Actinic Keratosis: European Multi-Criteria Decision Analysis (2026) Berking C, Botella R, Carugno A, Gambarelli G, Malvehy J, Moscarella E, Petracca A, et al. Journal article Melanoma of unknown primary shows an oncogenic pattern and clinical course of sun-exposed melanoma. (2026) Lodde G, Dollani J, Galetzka W, Mohr P, Meier F, Gutzmer R, Weichenthal M, et al. Journal article Transforming tumor cells into professional antigen-presenting cells using poly(β-amino ester) nanoparticles to deliver CD80-encoding mRNA (2026) Binder A, Bremm F, Feuchter N, Torres-Coll A, Kübel S, Berking C, Borrós S, et al. Journal article Systemic Treatment and Outcome in Erythrodermic Psoriasis: A Retrospective Multicenter Study (2026) Kögel J, Schuh S, Welzel J, Sticherling M, Sollfrank L, Berking C, Pumnea T, et al. Journal article Immune checkpoint inhibitor-induced bullous pemphigoid Immuncheckpointinhibitor-induziertes bullöses Pemphigoid (2026) Breakell T, Staats L, Berking C Journal article Management of Facial Immune Checkpoint Inhibitor-Induced Vitiligo with Topical Ruxolitinib: Quantitative Assessment Using a Semi-Automatic Tool. (2026) Breakell T, Neri P, Staats L, Kramer R, Berking C, Erdmann M, Hartmann A Journal article